tiprankstipranks
Trending News
More News >
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
US Market

Anavex Life Sciences (AVXL) Income Statement

Compare
1,728 Followers

Anavex Life Sciences Income Statement

Last quarter (Q3 2025), Anavex Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Anavex Life Sciences's net income was $-13.24M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 51.41M$ 52.88M$ 55.76M$ 50.99M$ 41.95M
Depreciation and Amortization
$ 0.00$ 50.59M$ -2.72M$ -3.32M$ 37.45M
EBITDA
$ 0.00$ 5.29M$ -55.76M$ -50.94M$ -37.38M
Operating Income
$ 0.00$ -52.88M$ -55.76M$ -50.99M$ -41.92M
Other Income/Expenses
$ 0.00$ 9.88M$ 8.26M$ 3.37M$ 4.28M
Pretax Income
$ 0.00$ -43.00M$ -47.50M$ -47.62M$ -37.64M
Net Income
$ 0.00$ -43.00M$ -47.51M$ -47.98M$ -37.91M
Per Share Metrics
Basic EPS
$ -0.54$ -0.52$ -0.60$ -0.62$ -0.54
Diluted EPS
$ -0.54$ -0.52$ -0.60$ -0.62$ -0.54
Weighted Average Shares Outstanding
85.29M 83.47M 79.79M 76.91M 69.80M
Weighted Average Shares Outstanding (Diluted)
85.29M 83.47M 79.79M 76.91M 69.80M
Currency in USD

Anavex Life Sciences Earnings and Revenue History